Essex Bio-Tech Declares HKD 0.07 Final Dividend for FY 2025

Bulletin Express03-23

Essex Bio-Technology Limited announced on 23 March 2026 that its board has proposed a final ordinary dividend of HKD 0.07 per share for the financial year ended 31 December 2025.

The dividend is subject to shareholder approval at the annual general meeting scheduled for 26 May 2026. Key timetable details released by the company are as follows:

• Ex-dividend date: 28 May 2026 • Last day to lodge share transfers: 29 May 2026 (16:30) • Book-closure period: 01 June 2026 – 03 June 2026 • Record date: 03 June 2026 • Payment date: 12 June 2026

Dividends will be paid in Hong Kong dollars through the company’s share registrar, Computershare Hong Kong Investor Services Limited. The announcement stated that no withholding tax applies to this dividend and confirmed there are no listed warrants or convertible securities tied to the payout.

As of the announcement date, the board comprises Executive Directors Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man, alongside Independent Non-Executive Directors Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1162158720?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-23 19:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162158720","market":"us","top_or_hot":-1,"title":"Essex Bio-Tech Declares HKD 0.07 Final Dividend for FY 2025","media":"Bulletin Express","content":"<p>Essex Bio-Technology Limited announced on 23 March 2026 that its board has proposed a final ordinary dividend of HKD 0.07 per share for the financial year ended 31 December 2025.</p>\n<p>The dividend is subject to shareholder approval at the annual general meeting scheduled for 26 May 2026. Key timetable details released by the company are as follows:</p>\n<p>• Ex-dividend date: 28 May 2026  \n• Last day to lodge share transfers: 29 May 2026 (16:30)  \n• Book-closure period: 01 June 2026 – 03 June 2026  \n• Record date: 03 June 2026  \n• Payment date: 12 June 2026</p>\n<p>Dividends will be paid in Hong Kong dollars through the company’s share registrar, Computershare Hong Kong Investor Services Limited. The announcement stated that no withholding tax applies to this dividend and confirmed there are no listed warrants or convertible securities tied to the payout.</p>\n<p>As of the announcement date, the board comprises Executive Directors Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man, alongside Independent Non-Executive Directors Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Essex Bio-Tech Declares HKD 0.07 Final Dividend for FY 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEssex Bio-Tech Declares HKD 0.07 Final Dividend for FY 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-23 19:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Essex Bio-Technology Limited announced on 23 March 2026 that its board has proposed a final ordinary dividend of HKD 0.07 per share for the financial year ended 31 December 2025.</p>\n<p>The dividend is subject to shareholder approval at the annual general meeting scheduled for 26 May 2026. Key timetable details released by the company are as follows:</p>\n<p>• Ex-dividend date: 28 May 2026  \n• Last day to lodge share transfers: 29 May 2026 (16:30)  \n• Book-closure period: 01 June 2026 – 03 June 2026  \n• Record date: 03 June 2026  \n• Payment date: 12 June 2026</p>\n<p>Dividends will be paid in Hong Kong dollars through the company’s share registrar, Computershare Hong Kong Investor Services Limited. The announcement stated that no withholding tax applies to this dividend and confirmed there are no listed warrants or convertible securities tied to the payout.</p>\n<p>As of the announcement date, the board comprises Executive Directors Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man, alongside Independent Non-Executive Directors Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01061","symbol_name":"亿胜生物科技","start_time":0,"source_url":"","article_id":"1162158720","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162158720","pubTimestamp":1774264846,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Essex Bio-Technology Limited announced on 23 March 2026 that its board has proposed a final ordinary dividend of HKD 0.07 per share for the financial year ended 31 December 2025. The dividend is...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01061":"亿胜生物科技"},"translate_title":"亿胜生物宣布派发2025财年末期股息0.07港元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01061":1},"content_text":"Essex Bio-Technology Limited announced on 23 March 2026 that its board has proposed a final ordinary dividend of HKD 0.07 per share for the financial year ended 31 December 2025.\nThe dividend is subject to shareholder approval at the annual general meeting scheduled for 26 May 2026. Key timetable details released by the company are as follows:\n• Ex-dividend date: 28 May 2026  \n• Last day to lodge share transfers: 29 May 2026 (16:30)  \n• Book-closure period: 01 June 2026 – 03 June 2026  \n• Record date: 03 June 2026  \n• Payment date: 12 June 2026\nDividends will be paid in Hong Kong dollars through the company’s share registrar, Computershare Hong Kong Investor Services Limited. The announcement stated that no withholding tax applies to this dividend and confirmed there are no listed warrants or convertible securities tied to the payout.\nAs of the announcement date, the board comprises Executive Directors Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man, alongside Independent Non-Executive Directors Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1162158720","isCrawlerRequest":true}